PMS2 mutations have been rare in Lynch syndrome, probably due to difficulties in their identification, but more recently these have been reported, predisposing to endometrial cancer with a relative risk of about twice higher than for colorectal cancer23,25–27. The gene discussed is PMS2; the disease is endometrial cancer.